Peroxisome proliferators activate growth regulatory pathways largely via peroxisome proliferator-activated receptor α-independent mechanisms

被引:34
|
作者
Pauley, CJ [1 ]
Ledwith, BJ [1 ]
Kaplanski, C [1 ]
机构
[1] Merck Res Labs, Dept Genet & Cellular Toxicol, West Point, PA 19486 USA
关键词
growth signalling; immediate early genes; peroxisome proliferators; hepatocarcinogenesis; PPAR alpha;
D O I
10.1016/S0898-6568(01)00260-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Peroxisome proliferators (PPs) induce liver tumors in rodents through an unknown mechanism requiring PP-activated receptor (PPAR) alpha. Since PPs possess growth modulatory activities that may be important to their hepatocarcinogenicity, we aimed at dissociating the activation of growth signaling pathways from the PPARalpha-mediated response induced by PPs in cultured rat primary hepatocytes. Pretreatment with the differentiation-promoting agent dimethylsulfoxide (DMSO) increased PPARalpha mRNA/protein and enhanced the expression of PPARalpha-regulated genes [fatty acyl Co-A oxidase (FACO), cytochrome P450 4A1 (CyT4A1)] induced by PPs. In contrast, DMSO reduced the expression of immediate early genes (IEG) expression (c-myc, c-jun, c-fos, junB, egr-1) and inhibited mitogen-activated protein Kinase (MEK) kinase/extracellular signal-regulated kinases (ERKs) and p38 phosphorylation. Furthermore, the inhibitors Tyrphostin and PD98059 dowregulated IEG/EFKs induction and slightly enhanced the FACO/CYP4A1 response induced by the PP WY-14,643 The stimulation of signal transduction pathways by PPs can be dissociated from PPARa activation, thus suggesting that PPs could activate growth regulatory pathways largely via PPARalpha-independent mechanisms. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:351 / 358
页数:8
相关论文
共 50 条
  • [32] Peroxisome proliferator-activated receptor α target genes
    Mandard, S
    Müller, M
    Kersten, S
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (04) : 393 - 416
  • [33] Peroxisome proliferator-activated receptor γ and metabolic disease
    Willson, TM
    Lambert, MH
    Kliewer, SA
    ANNUAL REVIEW OF BIOCHEMISTRY, 2001, 70 : 341 - 367
  • [34] The pleiotropic functions of peroxisome proliferator-activated receptor γ
    Debril, MB
    Renaud, JP
    Fajas, L
    Auwerx, J
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2001, 79 (01): : 30 - 47
  • [35] Peroxisome proliferator-activated receptor γ (PPARγ) and sepsis
    von Knethen, Andreas
    Soller, Mathias
    Bruene, Bernhard
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2007, 55 (01) : 19 - 25
  • [36] Peroxisome proliferator-activated receptor γ (PPARγ) and sepsis
    Andreas von Knethen
    Mathias Soller
    Bernhard Brüne
    Archivum Immunologiae et Therapiae Experimentalis, 2007, 55 : 19 - 25
  • [37] Evolution of peroxisome proliferator-activated receptor agonists
    Chang, Feng
    Jaber, Linda A.
    Berlie, Helen D.
    O'Connell, Mary Beth
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (06) : 973 - 983
  • [38] Peroxisome proliferator-activated receptor γ in diabetes and metabolism
    Rangwala, SM
    Lazar, MA
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (06) : 331 - 336
  • [39] PHYSIOLOGICAL FUNCTIONS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR β
    Neels, Jaap G.
    Grimaldi, Paul A.
    PHYSIOLOGICAL REVIEWS, 2014, 94 (03) : 795 - 858
  • [40] Peroxisome proliferator-activated receptor-γ and lipodystrophy
    Tantsma, Jouke T.
    Rabelink, Ton J.
    FUTURE LIPIDOLOGY, 2006, 1 (04): : 455 - 462